Conversations You Want About Corona Virus Disease (COVID-19)

NCT05191420 | Terminated

• 1 other identifier: IRB00075790
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Web-enabled virtual topical guide: develop virtual conversations for each concern and intensity level

Conditions

Covid19

Keywords

Vaccines

Outcome Measures

Primary Outcomes (6)

• Time spent with the guide

  Time spent with the guide

  Week 4

• Number of clinics viewed in the guide

  Number of clinics viewed in the guide

  Week 4

• Number of content areas accessed

  Number of content areas accessed

  Week 4

• Time spent with each content area

  Time spent with each content area

  Week 4

• Helpfulness of Tool

  How helpful was this tool in your decision-making, ranging from 1 not at all helpful to 5 incredibly helpful

  Week 4

• Number of Subjects saving responses

  Individuals will have the ability to send their guide responses to themselves for later use

  Week 4

Study Arms (1)

Virtual topical discussion guide

Study will pilot test this virtual topical discussion guide to assess feasibility and acceptability by diverse patient populations.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Diverse health care professions and community members

You may qualify if:

• greater than or equal to 18 years of age
• English or Spanish speaking only

You may not qualify if:

• less than 18 years of age
• not English or Spanish speaking

Sponsors & Collaborators

• Wake Forest University Health Sciences: lead

Study Sites (1)

Wake Forest Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Katherine A Poehling, MD

  Wake Forest Health Sciences

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 11, 2022
• First Posted: January 13, 2022
• Study Start: March 9, 2022
• Primary Completion: May 15, 2023
• Study Completion: May 15, 2023
• Last Updated: June 1, 2026

Record last verified: 2026-05

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)